Last Update

2016-09-13T00:00:00.000Z

This profile was last updated on .

Is this you? Claim your profile.

Wrong Donald Payan?

Dr. Donald G. Payan

Executive Vice President and President

Discovery

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Discovery

Background Information

Employment History

Executive Vice President and Chief Scientific Officer

Rigel Pharmaceuticals , Inc.

Cso

Khepri.com

Adjunct Professor of Medicine

University of California , San Francisco

Adjunct Professor of Medicine and Surgery

1982

Affiliations

Member
Howard Hughes Medical Institute

Board Member
Accelerated Pharma Inc

Member of SCIENTIFIC ADVISORY BOARD
Catalyst Biosciences Inc

Member, Advisory Board
Gladstone Institute At The University Of California

Board Member
The Vaccine Company

Board Member
Kinexis , Inc.

Board Member
Zengen , Inc.

Education

B.S.

Stanford University

M.D.

Stanford University

Web References (184 Total References)


Donald Payan, ...

apipharmaceuticals.com [cached]

Donald Payan, MD Director

Dr. Payan is a co-founder of Rigel Pharmaceutical. He was its first CEO and President. He has been a member of its Board of Directors since July 1996 and was appointed Executive Vice President and President of Discovery & Research in February 2008. From January 1997 to February 2008, Dr. Payan served as our Executive Vice President and Chief Scientific Officer. Prior to Rigel, Dr. Payan was Vice President of AxyS Pharmaceuticals (now Celera), a biopharmaceutical company, and Executive Vice President and Chief Scientific Officer of Khepri Pharmaceuticals, which he founded and subsequently merged with AxyS Pharmaceuticals. Dr. Payan is a former Professor at the University of California, San Francisco and Member of the Howard Hughes Medical Institute.


Donald G. Payan, MD - ...

www.rigel.com [cached]

Donald G. Payan, MD - Executive Vice President and President, Discovery & Research Donald G. Payan, M.D., one of Rigel's co-founders, has been a member of our Board of Directors since July 1996 and was appointed Executive Vice President and President of Discovery & Research in February 2008 . From January 1997 to February 2008, Dr. Payan served as our Executive Vice President and Chief Scientific Officer. Dr. Payan also served as Rigel's Chief Operating Officer from January 1997 to July 1998 and as our President and Chief Executive Officer from July 1996 to January 1997. Prior to Rigel, Dr. Payan was Vice President of AxyS Pharmaceuticals (now Celera), a biopharmaceutical company, and Executive Vice President and Chief Scientific Officer of Khepri Pharmaceuticals, which he founded and subsequently merged with AxyS Pharmaceuticals. Dr. Payan is a former Professor at the University of California, San Francisco and Member of the Howard Hughes Medical Institute. Dr. Payan holds an M.D. and a B.S. from Stanford University and completed his residencies and fellowships at the Massachusetts General Hospital and Harvard Medical School.


senior management: Rigel Pharmaceuticals

www.rigel.com [cached]

Donald G. Payan, MD

Donald G. Payan, M.D., one of Rigel's co-founders, has been a member of our Board of Directors since July 1996 and was appointed Executive Vice President and President of Discovery and Research in February 2008 . From January 1997 to February 2008, Dr. Payan served as our Executive Vice President and Chief Scientific Officer. Dr. Payan also served as Rigel's Chief Operating Officer from January 1997 to July 1998 and as our President and Chief Executive Officer from July 1996 to January 1997. Prior to Rigel, Dr. Payan was Vice President of AxyS Pharmaceuticals (now Celera), a biopharmaceutical company, and Executive Vice President and Chief Scientific Officer of Khepri Pharmaceuticals, which he founded and subsequently merged with AxyS Pharmaceuticals. Dr. Payan is a former Professor at the University of California, San Francisco and Member of the Howard Hughes Medical Institute. Dr. Payan holds an M.D. and a B.S. from Stanford University and completed his residencies and fellowships at the Massachusetts General Hospital and Harvard Medical School.


senior management: Rigel Pharmaceuticals

www.rigel.com [cached]

Donald G. Payan, MD

Donald G. Payan, M.D., one of Rigel's co-founders, has been a member of our Board since July 1996 and was appointed Executive Vice President and President of Discovery and Research in February 2008 . From January 1997 to February 2008, Dr. Payan served as our Executive Vice President and Chief Scientific Officer. Dr. Payan also served as Rigel's Chief Operating Officer from January 1997 to July 1998 and as our President and Chief Executive Officer from July 1996 to January 1997. Prior to Rigel, Dr. Payan was Vice President of AxyS Pharmaceuticals (now Celera), a biopharmaceutical company, and Executive Vice President and Chief Scientific Officer of Khepri Pharmaceuticals, which he founded and subsequently merged with AxyS Pharmaceuticals. Dr. Payan is a former Professor at the University of California, San Francisco and Member of the Howard Hughes Medical Institute. Dr. Payan holds an M.D. and a B.S. from Stanford University and completed his residencies and fellowships at the Massachusetts General Hospital and Harvard Medical School.


senior management: Rigel Pharmaceuticals

www.rigel.com [cached]

Donald G. Payan, MD

Donald G. Payan, M.D., one of Rigel's co-founders, has been a member of our Board since July 1996 and was appointed Executive Vice President and President of Discovery and Research in February 2008 . From January 1997 to February 2008, Dr. Payan served as our Executive Vice President and Chief Scientific Officer. Dr. Payan also served as Rigel's Chief Operating Officer from January 1997 to July 1998 and as our President and Chief Executive Officer from July 1996 to January 1997. Prior to Rigel, Dr. Payan was Vice President of AxyS Pharmaceuticals (now Celera), a biopharmaceutical company, and Executive Vice President and Chief Scientific Officer of Khepri Pharmaceuticals, which he founded and subsequently merged with AxyS Pharmaceuticals. Dr. Payan is a former Professor at the University of California, San Francisco and Member of the Howard Hughes Medical Institute. Dr. Payan holds an M.D. and a B.S. from Stanford University and completed his residencies and fellowships at the Massachusetts General Hospital and Harvard Medical School.

Similar Profiles

Other People with this Name

Other people with the name Payan

Rafael Payan
Carmel RIVER Watershed Conservancy Inc

Reyna Payan
Alexander Toyota

Mario Payan
Pacific Technical Sales Inc

Wendy Payan
National Institute of Clinical Research

Jay Payan
J. L. Payan & Associates Inc

Browse ZoomInfo's Business Contact Directory by City

Browse ZoomInfo's
Business People Directory

Browse ZoomInfo's
Advanced Company Directory